The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - CerFlux, Inc.
Research Funding - CerFlux, Inc.
Characterizing differential efficacy and phenotypic response to proteasome and survivin inhibitors in colorectal cancers using a high throughput organoid assay.
 
Dana Zuaiter
No Relationships to Disclose
 
Parmanand Ahirwar
No Relationships to Disclose
 
Aman G Pokal
No Relationships to Disclose
 
Zeelu H. Patel
Employment - CerFlux, Inc.
Research Funding - CerFlux, Inc.
 
Areesha A. Charania
Employment - CerFlux, Inc.
Research Funding - CerFlux, Inc.
 
Chelsea L. Crawford
No Relationships to Disclose
 
Mary Kathryn Sewell-Loftin
Employment - Cerflux, Inc.
Consulting or Advisory Role - Cerflux, Inc.
Research Funding - Cerflux, Inc.
 
Allan Tsung
No Relationships to Disclose
 
Alex Kim
No Relationships to Disclose
 
Karim I. Budhwani
Employment - CerFlux, Inc.
Leadership - CerFlux, Inc.
Stock and Other Ownership Interests - CerFlux, Inc.
Research Funding - CerFlux, Inc.
Patents, Royalties, Other Intellectual Property - 3 US, 1 EU, 1 UK patents issued. 6 additional patents pending. Broadly related to microfluidics, bioengineering, lab-chip, tissue, or tumor models.
Other Relationship - American Cancer Society; BIO Alabama; Breast Cancer Research Foundation of Alabama; O'Neal Comprehensive Cancer Center